1,765
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Insulin-induced lipid body accumulation is accompanied by lipid remodelling in model mast cells

, , , , ORCID Icon, , , , & ORCID Icon show all
Pages 265-279 | Received 20 Jan 2019, Accepted 20 Jun 2019, Published online: 16 Jul 2019

References

  • Templeman NM, Skovsø S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol. 2017 Mar;232:R173–R183.
  • Erion KA, Corkey BE. Hyperinsulinemia: a cause of obesity? Curr Obes Rep. 2017;6:178–186.
  • McLaughlin T, Ackerman SE, Shen L, et al. Role of innate and adaptive immunity in obesity-associated metabolic disease. J Clin Invest. 2017;127:5–13.
  • Patel PS, Buras ED, Balasubramanyam A. The role of the immune system in obesity and insulin resistance. J Obes. 2013;2013:616193.
  • Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017;2017:6494795.
  • Greineisen WE, Maaetoft-Udsen K, Speck M, et al. Chronic insulin exposure induces ER stress and lipid body accumulation in mast cells at the expense of their secretory degranulation response. PLoS One. 2015;10:e0130198.
  • Greineisen WE, Shimoda LM, Maaetoft-Udsen K, et al. Insulin-containing lipogenic stimuli suppress mast cell degranulation potential and up-regulate lipid body biogenesis and eicosanoid secretion in a PPARgamma-independent manner. J Leukoc Biol. 2012;92:653–665.
  • Greineisen WE, Speck M, Shimoda LM, et al. Lipid body accumulation alters calcium signaling dynamics in immune cells. Cell Calcium. 2014;56:169–180.
  • Jansen C, Speck M, Greineisen WE, Maaetoft-Udsen K, Cordasco E, Shimoda LM, Stokes AJ, Turner H. Transcriptional and Functional Plasticity Induced by Chronic Insulin Exposure in a Mast Cell-Like Basophilic Leukemia Cell Model. J Immunobiol. 2017;2. pii:135.
  • Dichlberger A, Kovanen PT, Schneider WJ. Mast cells: from lipid droplets to lipid mediators. Clin Sci (Lond). 2013;125:121–130.
  • Dichlberger A, Schlager S, Kovanen PT, et al. Lipid droplets in activated mast cells – a significant source of triglyceride-derived arachidonic acid for eicosanoid production. Eur J Pharmacol. 2016;785:59–69.
  • Dichlberger A, Schlager S, Lappalainen J, et al. Lipid body formation during maturation of human mast cells. J Lipid Res. 2011;52:2198–2208.
  • Triggiani M, Oriente A, de Crescenzo G, et al. Metabolism of lipid mediators in human basophils and mast cells. Chem Immunol. 1995;61:135–147.
  • Wendell SG, Baffi C, Holguin F. Fatty acids, inflammation, and asthma. J Allergy Clin Immunol. 2014;133:1255–1264.
  • Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45:1105–1115.
  • Taketomi Y, Murakami M. Immunological regulation by bioactive lipids. Yakugaku Zasshi. 2017;137:503–515.
  • Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther. 2018;186:98–113.
  • Bozza PT, Magalhaes KG, Weller PF. Leukocyte lipid bodies – biogenesis and functions in inflammation. Biochim Biophys Acta. 2009;1791:540–551.
  • Fonteh AN, Chilton FH. Mobilization of different arachidonate pools and their roles in the generation of leukotrienes and free arachidonic acid during immunologic activation of mast cells. J Immunol. 1993;150:563–570.
  • Friedrich M. Lipid remodeling and obesity. JAMA. 2011;306:257.
  • Surette ME, Winkler JD, Fonteh AN, et al. Relationship between arachidonate–phospholipid remodeling and apoptosis. Biochemistry. 1996;35:9187–9196.
  • Chilton FH, Fonteh AN, Surette ME, et al. Control of arachidonate levels within inflammatory cells. Biochim Biophys Acta. 1996;1299:1–15.
  • Boyce JA. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev. 2007;217:168–185.
  • Kabashima K, Nakashima C, Nonomura Y, et al. Biomarkers for evaluation of mast cell and basophil activation. Immunol Rev. 2018;282:114–120.
  • Liu HQ, Qiu Y, Mu Y, et al. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats. Nutr Res. 2013;33:849–858.
  • Kalogeropoulos N, Panagiotakos DB, Pitsavos C, et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta. 2010;411:584–591.
  • Maaetoft-Udsen K, Greineisen WE, Aldan JT, et al. Comparative analysis of lipotoxicity induced by endocrine, pharmacological, and innate immune stimuli in rat basophilic leukemia cells. J Immunotoxicol. 2015;12:385–394.
  • Passante E, Frankish N. The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell. Inflamm Res. 2009;58:737–745.
  • Melo RC, Weller PF. Lipid droplets in leukocytes: organelles linked to inflammatory responses. Exp Cell Res. 2016;340:193–197.
  • Weller PF, Dvorak AM. Lipid bodies: intracellular sites for eicosanoid formation. J Allergy Clin Immunol. 1994;94:1151–1156.
  • Ding J, Nagai K, JT W. Insulin-dependent adipogenesis in stromal ST2 cells derived from murine bone marrow. Biosci Biotechnol Biochem. 2003;67:314–321.
  • D’Avila H, Roque NR, Cardoso RM, et al. Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell Microbiol. 2008;10:2589–2604.
  • Araujo-Santos T, Prates DB, Andrade BB, et al. Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E(2) production in murine macrophages. PLoS Negl Trop Dis. 2010;4:e873.
  • Gemmink A, Daemen S, Kuijpers HJH, et al. Super-resolution microscopy localizes perilipin 5 at lipid droplet-mitochondria interaction sites and at lipid droplets juxtaposing to perilipin 2. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863:1423–1432.
  • Klecker T, Braun RJ, Westermann B. Lipid Droplets Guard Mitochondria during Autophagy. Dev Cell. 2017;42:1–2.
  • Yu J, Zhang S, Cui L, et al. Lipid droplet remodeling and interaction with mitochondria in mouse brown adipose tissue during cold treatment. Biochim Biophys Acta. 2015;1853:918–928.
  • Chang WH, Ting HC, Chen WW, et al. Omega-3 and omega-6 fatty acid differentially impact cardiolipin remodeling in activated macrophage. Lipids Health Dis. 2018;17:201.
  • Leung CW, Hong Y, Hanske J, et al. Superior fluorescent probe for detection of cardiolipin. Anal Chem. 2014;86:1263–1268.
  • Weller PF. Leukocyte lipid bodies – structure and function as “Eicosasomes”. Trans Am Clin Climatol Assoc. 2016;127:328–340.
  • Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol. 2010;40:1843–1851.
  • Noli C, Miolo A. The mast cell in wound healing. Vet Dermatol. 2001;12:303–313.
  • Bays H. Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014;16:409.
  • Zelechowska P, Agier J, Kozlowska E, et al. Mast cells participate in chronic low-grade inflammation within adipose tissue. Obes Rev. 2018;19:686–697.
  • Shi MA, Shi GP. Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans. Front Immunol. 2012;3:7.
  • Wang J, Shi GP. Mast cell stabilization: novel medication for obesity and diabetes. Diabetes Metab Res Rev. 2011;27:919–924.
  • Zhang J, Shi GP. Mast cells and metabolic syndrome. Biochim Biophys Acta. 2012;1822:14–20.
  • Liu J, Divoux A, Sun J, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009;15:940–945.
  • Pietilainen KH, Rog T, Seppanen-Laakso T, et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol. 2011;9:e1000623.
  • Quehenberger O, Armando A, Dumlao D, et al. Lipidomics analysis of essential fatty acids in macrophages. Prostaglandins Leukot Essent Fatty Acids. 2008;79:123–129.
  • Yetukuri L, Katajamaa M, Medina-Gomez G, et al. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol. 2007;1:12.
  • Fonteh AN, Chilton FH. Rapid remodeling of arachidonate from phosphatidylcholine to phosphatidylethanolamine pools during mast cell activation. J Immunol. 1992;148:1784–1791.
  • Garcia-Gil M, Siraganian RP. Source of the arachidonic acid released on stimulation of rat basophilic leukemia cells. J Immunol. 1986;136:3825–3828.
  • Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. 2015;64:27–34.
  • Saito P, Melo CPB, Martinez RM, et al. The lipid mediator resolvin D1 reduces the skin inflammation and oxidative stress induced by UV irradiation in hairless mice. Front Pharmacol. 2018;9:1242.
  • Martin N, Ruddick A, Arthur GK, et al. Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. PLoS One. 2012;7:e43545.